Yale Study – Adequate Core Biopsy Samples from Stereotactic Biopsies Needed for Today’s Breast Pathology
Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies Needed for Today’s Breast Pathology
Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided Mammotome vacuum device
A comprehensive evaluation of 8-gauge vacuum-assisted Mammotome system for ultrasound-guided diagnostic biopsy and selective excision of breast lesions
Large volume ‘‘mammotome’’ biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast
A clinical study by Seoul National University Bundang Hospital finds Mammotome elite 13 gauge accurately samples tissue and improves patient outcomes.
Mammotome elite 13 gauge successfully and accurately samples all lesions and reduces underestimation rate compared to a 14-gauge core needle for non-mass breast lesions under ultrasound guided breast biopsy
There is a paradigm shift in breast biopsy philosophy. In the past radiologists and clinicians used to collect as little tissue as possible for pathologists to render a diagnosis on conventional histologic H&E sections.
“We have had the opportunity to work with the Mammotome elite since its release in 2012 and I currently use it for all my ultrasound-guided procedures.”
Mammotome® elite™ offers the best of both worlds—an easy-to-use and efficient device that acquires consistent quality tissue samples. With multiple interventional breast radiologists in my practice, the Mammotome® elite™ platform offers an added advantage of a quick learning curve that is easy to integrate.
Breast biopsy devices that require multiple insertions present a challenge when biopsying small lesions. As samples are acquired with these devices, it becomes more difficult to visualize the area of concern, requiring more time scanning and targeting with each subsequent sample.
When microcalcifications were visible under ultrasound in the past, we were confronted with a difficult decision when wanting to perform an ultrasound-guided biopsy.
This suspicious solid lesion presented a challenging sampling scenario due to its close proximity to the breast implant. With a spring-loaded device, it would have been difficult to obtain samples without fear of damaging the underlying implant capsule.
Sampling of the enlarging solid mass in this patient with a history of left breast cancer and implant reconstruction presented a great challenge due to its very close proximity to the implant and immediately beneath the skin.
Multiple samples of complex cystic masses are often difficult to obtain using a spring-loaded device. If the mass deflates after the initial sample, visualization of the remaining mass becomes difficult, reducing the confidence of sample accuracy.
Posterior masses can be challenging for both ultrasound and stereotactic biopsy due to concerns about their location relative to the patient’s chest wall. The Mammotome® elite™ device provides many benefits in procedures involving lesions near the chest wall.
For years we have performed spring-loaded core biopsy of the axillary lymph nodes when the lymph nodes show evidence of malignant modifications. In general, we have seen good correlation and have recommended lymph node dissection of the axilla.
Mammotome elite is the only single-insertion, tetherless device with TruVac vacuum technology. Combining vacuum-assisted biopsy tissue quality with the ease and speed of a core needle, Mammotome elite is raising the bar in breast biopsy.
The methods of diagnosing breast disease have continuously changed over the last few decades. During this time, standard diagnostic technique has evolved from open surgical biopsy to minimally invasive breast biopsy [MIBB] which provides a confident diagnosis while minimizing procedure time, cost and morbidity.